These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9080470)

  • 21. Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.
    Psylla M; Günther I; Antonini A; Vontobel P; Reist HW; Zollinger A; Leenders KL
    Brain Res; 1997 Aug; 767(1):45-54. PubMed ID: 9365014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic positron emission tomography studies: demonstration of a deuterium isotope effect in the monoamine oxidase-catalyzed binding of [11C]L-deprenyl in living baboon brain.
    Fowler JS; Wolf AP; MacGregor RR; Dewey SL; Logan J; Schlyer DJ; Langstrom B
    J Neurochem; 1988 Nov; 51(5):1524-34. PubMed ID: 3139834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of [11C]GB67, a novel radioligand for imaging myocardial alpha 1-adrenoceptors with positron emission tomography.
    Law MP; Osman S; Pike VW; Davenport RJ; Cunningham VJ; Rimoldi O; Rhodes CG; Giardinà D; Camici PG
    Eur J Nucl Med; 2000 Jan; 27(1):7-17. PubMed ID: 10654141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-[18F]fluoro-L-DOPA uptake in the rat pancreas is dependent on the tracer metabolism.
    Kalliokoski T; Tuomela J; Haavisto L; Forsback S; Snellman A; Helin S; Grönroos TJ; Solin O; Haaparanta-Solin M
    Mol Imaging Biol; 2014 Jun; 16(3):403-11. PubMed ID: 24217945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
    Treseder SA; Rose S; Jenner P
    Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
    Tayarani-Binazir KA; Jackson MJ; Fisher R; Zoubiane G; Rose S; Jenner P
    Eur J Pharmacol; 2010 Jun; 635(1-3):109-16. PubMed ID: 20303948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral uptake and utilization of therapeutic [beta-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor response.
    Tedroff J; Aquilonius SM; Hartvig P; Bredberg E; Bjurling P; Långström B
    Acta Neurol Scand; 1992 Feb; 85(2):95-102. PubMed ID: 1574995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521.
    Cumming P; Boyes BE; Martin WR; Adam M; Ruth TJ; McGeer EG
    Biochem Pharmacol; 1987 Aug; 36(15):2527-31. PubMed ID: 3111485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
    Silva MA; Mattern C; Häcker R; Tomaz C; Huston JP; Schwarting RK
    Synapse; 1997 Dec; 27(4):294-302. PubMed ID: 9372552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreas.
    Di Gialleonardo V; Signore A; Scheerstra EA; Visser AK; van Waarde A; Dierckx RA; de Vries EF
    J Nucl Med; 2012 Nov; 53(11):1755-63. PubMed ID: 23000748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
    Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, in vivo evaluation and PET study of a carbon-11-labeled neuronal nitric oxide synthase (nNOS) inhibitor S-methyl-L-thiocitrulline.
    Zhang J; Xu M; Dence CS; Sherman EL; McCarthy TJ; Welch MJ
    J Nucl Med; 1997 Aug; 38(8):1273-8. PubMed ID: 9255165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of L-dopa administration on islet monoamine oxidase activity and glucose-induced insulin release in the mouse.
    Lundquist I; Panagiotidis G; Stenström A
    Pancreas; 1991 Sep; 6(5):522-7. PubMed ID: 1946308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms.
    Cumming P; Gjedde A
    Synapse; 1998 May; 29(1):37-61. PubMed ID: 9552174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography.
    Orlefors H; Sundin A; Lu L; Oberg K; Långström B; Eriksson B; Bergström M
    Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):60-5. PubMed ID: 16184369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiolabeled neuronal nitric oxide synthase inhibitors: synthesis, in vivo evaluation, and primate PET studies.
    Pomper MG; Musachio JL; Scheffel U; Macdonald JE; McCarthy DJ; Reif DW; Villemagne VL; Yokoi F; Dannals RF; Wong DF
    J Nucl Med; 2000 Aug; 41(8):1417-25. PubMed ID: 10945536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of reserpine on the brain uptake of carbon 11 methamphetamine and its N-propagyl derivative, deprenyl.
    Inoue O; Axelsson S; Lundqvist H; Oreland L; Långström B
    Eur J Nucl Med; 1990; 17(3-4):121-6. PubMed ID: 2126235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute inhibition of cardiac monoamine oxidase A after tobacco smoke inhalation: validation study of [11C]befloxatone in rats followed by a positron emission tomography application in baboons.
    Valette H; Bottlaender M; Dollé F; Coulon C; Ottaviani M; Syrota A
    J Pharmacol Exp Ther; 2005 Jul; 314(1):431-6. PubMed ID: 15833896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cerebral metabolism of L-dihydroxyphenylalanine. An autoradiographic and biochemical study.
    Horne MK; Cheng CH; Wooten GF
    Pharmacology; 1984; 28(1):12-26. PubMed ID: 6701184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.